Yield10 Bioscience, Inc.
YTEN · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $5 | $3 | $3 |
| - Cash | $1 | $2 | $1 | $3 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $3 | $6 | $5 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 50% | 400% | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 100% | 100% | -21.7% | – |
| EBITDA | -$3 | -$2 | -$3 | -$4 |
| % Margin | -698.4% | -791.3% | -5,290% | – |
| Net Income | -$3 | -$2 | -$3 | -$4 |
| % Margin | -719.6% | -824% | -5,443.3% | – |
| EPS Diluted | -5.04 | -4.77 | -6.54 | -9.95 |
| % Growth | -5.7% | 27.1% | 34.3% | – |
| Operating Cash Flow | -$1 | -$1 | -$2 | -$3 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$2 | -$3 |